Analystreport

Rocket Pharmaceuticals (NASDAQ:RCKT) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.

Rocket Pharmaceuticals, Inc.  (RCKT) 
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rocketpharma.com